Oosterwijk E - Search Results

1

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.

Uemura H, Nakagawa Y, Yoshida K, Saga S, Yoshikawa K, Hirao Y, Oosterwijk E. Uemura H, et al. Among authors: oosterwijk e. Br J Cancer. 1999 Oct;81(4):741-6. doi: 10.1038/sj.bjc.6690757. Br J Cancer. 1999. PMID: 10574265 Free PMC article.

2

Internal image anti-idiotype antibodies related to renal-cell carcinoma-associated antigen G250.

Uemura H, Okajima E, Debruyne FM, Oosterwijk E. Uemura H, et al. Among authors: oosterwijk e. Int J Cancer. 1994 Feb 15;56(4):609-14. doi: 10.1002/ijc.2910560424. Int J Cancer. 1994. PMID: 7509324

3

Radiolabeled monoclonal antibody G250 in renal-cell carcinoma.

Oosterwijk E, Debruyne FM. Oosterwijk E, et al. World J Urol. 1995;13(3):186-90. doi: 10.1007/BF00184877. World J Urol. 1995. PMID: 7550393 Free article. Clinical Trial.

4

Immunization with anti-idiotype monoclonal antibodies bearing the internal image of the renal-cell carcinoma-associated antigen G250 induces specific cellular immune responses.

Uemura H, Okajima E, Debruyne FM, Oosterwijk E. Uemura H, et al. Among authors: oosterwijk e. Int J Cancer. 1994 Dec 15;59(6):802-7. doi: 10.1002/ijc.2910590616. Int J Cancer. 1994. PMID: 7989122

5

Vaccination with anti-idiotype antibodies mimicking a renal cell carcinoma-associated antigen induces tumor immunity.

Uemura H, Beniers AJ, Okajima E, Debruyne FM, Oosterwijk E. Uemura H, et al. Among authors: oosterwijk e. Int J Cancer. 1994 Aug 15;58(4):555-61. doi: 10.1002/ijc.2910580418. Int J Cancer. 1994. PMID: 8056452

6

Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.

van Dijk J, Uemura H, Beniers AJ, Peelen WP, Zegveld ST, Fleuren GJ, Warnaar SO, Oosterwijk E. van Dijk J, et al. Among authors: oosterwijk e. Int J Cancer. 1994 Jan 15;56(2):262-8. doi: 10.1002/ijc.2910560220. Int J Cancer. 1994. PMID: 8314310

7

Detection of DNA amplification in human renal cell carcinoma cell lines using restriction landmark genomic scanning.

Cho M, Konishi N, Kitahori Y, Hiasa Y, Nakagawa Y, Uemura H, Hirao Y, Oosterwijk E. Cho M, et al. Among authors: oosterwijk e. Cell Mol Biol (Noisy-le-grand). 1998 Sep;44(6):913-8. Cell Mol Biol (Noisy-le-grand). 1998. PMID: 9763194

8

Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma.

Shimazui T, Oosterwijk E, Akaza H, Bringuier P, Ruijter E, van Berkel H, Wakka JO, van Bokhoven A, Debruyne FM, Schalken JA. Shimazui T, et al. Among authors: oosterwijk e. Clin Cancer Res. 1998 Oct;4(10):2419-24. Clin Cancer Res. 1998. PMID: 9796973

9

Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas.

Steffens MG, Oosterwijk E, Zegwaart-Hagemeier NE, van't Hof MA, Debruyne FM, Corstens FH, Boerman OC. Steffens MG, et al. Among authors: oosterwijk e. Br J Cancer. 1998 Nov;78(9):1208-13. doi: 10.1038/bjc.1998.656. Br J Cancer. 1998. PMID: 9820182 Free PMC article.

10

Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapy.

Steffens MG, Boerman OC, Oyen WJ, Kniest PH, Witjes JA, Oosterhof GO, van Leenders GJ, Debruyne FM, Corstens FH, Oosterwijk E. Steffens MG, et al. Among authors: oosterwijk e. Cancer Res. 1999 Apr 1;59(7):1615-9. Cancer Res. 1999. PMID: 10197637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters